Method, kit or diagnostic for the detection of reagents which induce altered contractility
AssigneeThe Johns Hopkins University
InventorsChristopher I. Murray, Jennifer E. Van Eyk, Nazareno Paolocci, Wei Dong Gao, Darren Brian Foster
Life of this patent
Estimating the term…
Abstract
A method of screening for compounds that enhance or depress contractile function, based on measuring the formation of heterodimers of contractile fibers (e.g. Tm and actin, myosin heavy and myosin light chains), for example through disulfide bond formation. Diagnostic and prognostic methods and kits are also provided.
Claims32
A method for screening for an agent that increases contractility in a contractile cell comprising the steps of:
- a. contracting a test agent with a composition comprising contractile proteins from said cell;
- and
- b. measuring the formation of at least one cross link to form a heterodimer between said contractile proteins,
- wherein the formation of at least one cross link between said proteins is indicative of an potential agent for increasing contractility of said cell.
A method for screening for an agent that reduces contractility in a contractile cell comprising the steps of:
- a. contracting a test agent with a composition comprising contractile proteins from said cell in heterodimer form;
- and
- b. measuring the disruption of at least one cross link between said contractile proteins;
- wherein the disruption of at least one cross link between said proteins is indicative of a potential agent for decreasing contractility of said cell.
A diagnostic method comprising the step of detecting and/or measuring the level of a heterodimer comprised of contractile proteins in a biological sample wherein the presence and/or level of said heterodimer is correlated with a diagnosis, prognosis or treatment outcome.
A kit for screening for an agent that modifies cellular contractility, said kit comprising at least one antibody directed to a contractile protein, a denaturing gel, and a control sample comprising a contractile protein in homodimeric form.
An isolated biomarker comprising a heterodimer comprised of contractile proteins, wherein the presence of said biomarker in a biological sample is indicative of altered contractility of a contractile cell.
An isolated biomarker consisting of cross-linked contractile proteins having a molecular weight which indicate the presence of a heterodimer.
Dependencies are inferred from the claim text.